M T Deavers

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. pmc Monocyte/macrophage and T-cell infiltrates in peritoneum of patients with ovarian cancer or benign pelvic disease
    Xipeng Wang
    Department of Obstetrics and Gynecology, Renji Hospital, Shanghai Tiao Tong University, Shanghai, China
    J Transl Med 4:30. 2006
  2. ncbi request reprint Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential: a study of 99 advanced stage cases
    Michael T Deavers
    Department of Pathology and Gynecologic Oncology, University of Texas, Anderson Cancer Center, Houston, Texas 77030, USA
    Am J Surg Pathol 26:1129-41. 2002
  3. doi request reprint Immunohistochemistry in gynecologic pathology
    Michael T Deavers
    Department of Pathology, Box 85, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Arch Pathol Lab Med 132:175-80. 2008
  4. ncbi request reprint Immunohistochemistry in gynecological pathology
    M T Deavers
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Gynecol Cancer 13:567-79. 2003
  5. ncbi request reprint Ovarian sex cord-stromal tumors: an immunohistochemical study including a comparison of calretinin and inhibin
    Michael T Deavers
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Mod Pathol 16:584-90. 2003
  6. ncbi request reprint Serous tumors involving extra-abdominal/extra-pelvic sites after the diagnosis of an ovarian serous neoplasm of low malignant potential
    A Malpica
    Department of Pathology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Am J Surg Pathol 25:988-96. 2001
  7. ncbi request reprint Uterine tumor resembling ovarian sex-cord tumor: report of a case mimicking cervical adenocarcinoma
    Wareef Kabbani
    Department of Pathalogy, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Int J Gynecol Pathol 22:297-302. 2003
  8. ncbi request reprint Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas
    Koushan Siami
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    Am J Surg Pathol 31:1759-63. 2007
  9. ncbi request reprint Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum
    Kathleen M Schmeler
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, 1155 Herman Pressler Drive, Houston, TX 77030, USA
    Gynecol Oncol 108:510-4. 2008
  10. doi request reprint Primary peritoneal serous carcinoma presenting as inflammatory breast cancer
    Ibrahim Khalifeh
    Department of Pathology, MD Anderson Cancer Center, Houston, Texas, USA
    Breast J 15:176-81. 2009

Detail Information

Publications90

  1. pmc Monocyte/macrophage and T-cell infiltrates in peritoneum of patients with ovarian cancer or benign pelvic disease
    Xipeng Wang
    Department of Obstetrics and Gynecology, Renji Hospital, Shanghai Tiao Tong University, Shanghai, China
    J Transl Med 4:30. 2006
    ..Here, we examined peritoneal inflammatory cell patterns to determine their concordance with selected enhanced genes...
  2. ncbi request reprint Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential: a study of 99 advanced stage cases
    Michael T Deavers
    Department of Pathology and Gynecologic Oncology, University of Texas, Anderson Cancer Center, Houston, Texas 77030, USA
    Am J Surg Pathol 26:1129-41. 2002
    ..Additionally, our long-term follow-up of patients with typical SLMP indicates that a number of these tumors do not follow a benign course and supports their continued designation as borderline neoplasms...
  3. doi request reprint Immunohistochemistry in gynecologic pathology
    Michael T Deavers
    Department of Pathology, Box 85, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Arch Pathol Lab Med 132:175-80. 2008
    ..The following case studies are used to illustrate the value of some relatively new markers in the diagnosis of gynecologic neoplasms and to highlight potential diagnostic pitfalls...
  4. ncbi request reprint Immunohistochemistry in gynecological pathology
    M T Deavers
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Gynecol Cancer 13:567-79. 2003
    ..Differential diagnostic problems and relevant immunohistochemical stains for the vulva, vagina, cervix, uterus, and ovary are also addressed...
  5. ncbi request reprint Ovarian sex cord-stromal tumors: an immunohistochemical study including a comparison of calretinin and inhibin
    Michael T Deavers
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Mod Pathol 16:584-90. 2003
    ..Finally, these results demonstrate that calretinin is at least as sensitive as inhibin for ovarian SCSTs overall and that it is more sensitive than inhibin for fibromas and FTs...
  6. ncbi request reprint Serous tumors involving extra-abdominal/extra-pelvic sites after the diagnosis of an ovarian serous neoplasm of low malignant potential
    A Malpica
    Department of Pathology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Am J Surg Pathol 25:988-96. 2001
    ..Based on the LN involvement and the endosalpingiosis seen in some cases, these tumors might develop from circulating neoplastic serous cells or from areas of endosalpingiosis involving extra-abdominal/extra-pelvic sites...
  7. ncbi request reprint Uterine tumor resembling ovarian sex-cord tumor: report of a case mimicking cervical adenocarcinoma
    Wareef Kabbani
    Department of Pathalogy, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Int J Gynecol Pathol 22:297-302. 2003
    ....
  8. ncbi request reprint Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas
    Koushan Siami
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    Am J Surg Pathol 31:1759-63. 2007
    ..It should also be taken into consideration in the evaluation of adenocarcinomas involving the lung in patients with a history of a gynecologic malignancy...
  9. ncbi request reprint Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum
    Kathleen M Schmeler
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, 1155 Herman Pressler Drive, Houston, TX 77030, USA
    Gynecol Oncol 108:510-4. 2008
    ..To evaluate the response of women with low-grade serous carcinoma of the ovary or peritoneum to platinum-based neoadjuvant chemotherapy...
  10. doi request reprint Primary peritoneal serous carcinoma presenting as inflammatory breast cancer
    Ibrahim Khalifeh
    Department of Pathology, MD Anderson Cancer Center, Houston, Texas, USA
    Breast J 15:176-81. 2009
    ..To our knowledge, this is the first reported case of an extramammary primary malignancy that not only presented as inflammatory breast cancer but also was diagnosed and initially treated as such...
  11. ncbi request reprint Malignant melanoma involving the ovary: a clinicopathologic and immunohistochemical study of 23 cases
    Deepali Gupta
    Department of Pathology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Am J Surg Pathol 28:771-80. 2004
    ..S-100 is the most sensitive marker. MART-1 was positive in the few cases that were negative with HMB-45. Inhibin can be focally positive in some cases...
  12. ncbi request reprint Discordant genetic changes in ovarian and endometrial endometrioid carcinomas: a potential pitfall in molecular diagnosis
    K H Chang
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030 4095, USA
    Int J Gynecol Cancer 16:178-82. 2006
    ..Because of these discordant genetic changes, great caution should be taken when distinguishing between primary and metastatic tumors on the basis of microsatellite markers...
  13. ncbi request reprint Benign cystic mesothelioma of the peritoneum: a clinicopathologic study of 17 cases and immunohistochemical analysis of estrogen and progesterone receptor status
    Ravindranauth N Sawh
    Division of Pathology and Laboratory Medicine, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Hum Pathol 34:369-74. 2003
    ..Hum Pathol 34:369-374...
  14. ncbi request reprint Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases
    Emanuela Veras
    Department of Pathology, The University of Texas Medical School at Houston, Houston, TX 77030, USA
    Am J Surg Pathol 31:774-82. 2007
    ....
  15. ncbi request reprint Ovarian endometriosis associated with carcinoma and sarcoma: case report
    M C Boruban
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030 1439, USA
    Eur J Gynaecol Oncol 29:393-6. 2008
    ..She was again treated with doxorubicin and ifosfamide. The optimal treatment for endometriosis-associated ovarian cancer depends on the type of malignancy; simultaneously occurring multiple tumor types should be treated individually...
  16. ncbi request reprint Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a potential pitfall
    Monica A Recine
    Department of Pathology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Am J Surg Pathol 28:1646-51. 2004
    ..Clinical history, the presence of papillary architecture, and WT-1 expression are useful in establishing the correct diagnosis...
  17. ncbi request reprint Comparison of the clinical behavior of newly diagnosed stages II-IV low-grade serous carcinoma of the ovary with that of serous ovarian tumors of low malignant potential that recur as low-grade serous carcinoma
    Hyun S Shvartsman
    Department of Gynecologic Oncology, Unit 1362, The University of Texas M D Anderson Cancer Center, Houston, TX 77230 1439, USA
    Gynecol Oncol 105:625-9. 2007
    ..The purpose of this study was to compare the outcomes of patients with these two tumor types...
  18. ncbi request reprint Endometrioid carcinoma simultaneously involving the uterus and the fallopian tube: a clinicopathologic study of 13 cases
    Lisa K Culton
    Department of Pathology, The University of Texas Medical School at Houston, Houston, TX, USA
    Am J Surg Pathol 30:844-9. 2006
    ..The tumors are predominantly well or moderately differentiated with dissimilar endometrial and FT grades. The FT carcinoma is usually unilateral and located at the distal end of the tube...
  19. ncbi request reprint Ovarian steroid cell tumors: an immunohistochemical study including a comparison of calretinin with inhibin
    Michael T Deavers
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Int J Gynecol Pathol 22:162-7. 2003
    ..MART-1 (Ab3) immunostaining may be useful for cases in which melanoma is considered in the differential diagnosis...
  20. ncbi request reprint Peritoneal lesions in guinea pigs treated with hormones
    Elvio G Silva
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston 77030, USA
    Int J Gynecol Pathol 21:412-5. 2002
    ..This finding is relevant to understanding the pathogenesis of both fibrous lesions associated with ovarian tumors and peritoneal leiomyomatosis...
  21. ncbi request reprint Ovarian mixed-epithelial carcinomas with a microcystic pattern and signet-ring cells
    M Che
    Department of Pathology, Box 85, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
    Int J Gynecol Pathol 20:323-8. 2001
    ..It is important for pathologists to recognize these unusual findings in ovarian neoplasms, because they may produce a confusing apperance, even potentially suggesting a metastasis...
  22. doi request reprint Immunohistochemical studies of trophoblastic tumors
    Neda Kalhor
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Am J Surg Pathol 33:633-8. 2009
    ..However, the distinction of ITTs from choriocarcinoma cannot be accomplished on immunohistochemical studies, as they have similar immunophenotypes...
  23. ncbi request reprint Overexpression of the centrosomal protein Aurora-A kinase is associated with poor prognosis in epithelial ovarian cancer patients
    Charles N Landen
    Department of Gynecologic Oncology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Clin Cancer Res 13:4098-104. 2007
    ..To assess the clinical significance of Aurora-A kinase, a centrosome-regulating serine-threonine kinase, in ovarian carcinoma...
  24. doi request reprint Primary peritoneal cancer after bilateral salpingo-oophorectomy in two patients with Lynch syndrome
    Kathleen M Schmeler
    Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77230 1439, USA
    Obstet Gynecol 115:432-4. 2010
    ..We describe two cases of primary peritoneal cancer after BSO in women with Lynch syndrome or HNPCC...
  25. doi request reprint Prevalence of lymph node metastasis in primary mucinous carcinoma of the ovary
    Kathleen M Schmeler
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77230 1439, USA
    Obstet Gynecol 116:269-73. 2010
    ..To estimate the prevalence of lymph node involvement in women with primary mucinous ovarian carcinomas...
  26. ncbi request reprint Periosteal margin in soft-tissue sarcoma
    Patrick P Lin
    Section of Orthopaedic Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas 77230, USA
    Cancer 109:598-602. 2007
    ..Soft-tissue sarcomas frequently rest in contact with bone. The purpose of the study was to evaluate the risk of local recurrence for sarcomas adjacent to bone and to determine whether the periosteum provides an adequate margin of resection...
  27. ncbi request reprint Chemotherapy response is an important predictor of local recurrence in Ewing sarcoma
    Patrick P Lin
    Department of Orthopaedic Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas 77230, USA
    Cancer 109:603-11. 2007
    ..Local recurrence in Ewing sarcoma is associated with a poor prognosis. The purpose of the study was to determine the factors that predict local recurrence after surgical treatment of the primary tumor...
  28. pmc Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis
    Anil K Sood
    Department of Gynecologic Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    J Clin Invest 120:1515-23. 2010
    ....
  29. pmc BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas
    Kwong Kwok Wong
    Departments of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Am J Pathol 177:1611-7. 2010
    ..In addition, advanced-stage, low-grade carcinoma patients with BRAF or KRAS mutation have a better apparent clinical outcome. However, further investigation is needed...
  30. ncbi request reprint Postirradiation osteosarcoma of the mandible with heterologous differentiation
    Raja R Seethala
    Department of Pathology, M D Anderson Cancer Center, Houston, TX 77030, USA
    Arch Pathol Lab Med 130:385-8. 2006
    ..To our knowledge, this is the first report of osteosarcoma of the mandible with heterologous differentiation...
  31. ncbi request reprint Undifferentiated carcinoma of the endometrium: a review
    Elvio G Silva
    Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Pathology 39:134-8. 2007
    ....
  32. ncbi request reprint Significantly greater expression of ER, PR, and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysis
    Kwong Kwok Wong
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Int J Gynecol Pathol 26:404-9. 2007
    ..These differences may lead to the development of different therapeutic strategies for women with either the low-grade or the high-grade form of OSC...
  33. doi request reprint Anti-phosphorylated histone H3 expression in Barrett's esophagus, low-grade dysplasia, high-grade dysplasia, and adenocarcinoma
    Mahmoud Goodarzi
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Mod Pathol 22:1612-21. 2009
    ..In addition, phosphorylated histone H3 is a potential supportive marker to histology in differentiating low-grade dysplasia from indefinite for dysplasia and high-grade dysplasia from adenocarcinoma in the mucosal biopsy samples...
  34. doi request reprint Patterns of metastasis in sex cord-stromal tumors of the ovary: Can routine staging lymphadenectomy be omitted?
    Jubilee Brown
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, 1155 Herman Pressler Blvd, Unit 1362, P O Box 301439, TX 77230 1439, USA
    Gynecol Oncol 113:86-90. 2009
    ..Given the paucity of data regarding the patterns of metastasis from ovarian sex cord-stromal tumors (SCSTs), we sought to determine the risk of lymph node metastasis in patients with SCSTs...
  35. pmc Dicer, Drosha, and outcomes in patients with ovarian cancer
    William M Merritt
    University of Texas M D Anderson Cancer Center, Houston, TX 77230, USA
    N Engl J Med 359:2641-50. 2008
    ..We studied Dicer and Drosha, components of the RNA-interference machinery, in ovarian cancer...
  36. doi request reprint The significance of neuroendocrine expression in undifferentiated carcinoma of the endometrium
    Suad H Taraif
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Texas 77030, USA
    Int J Gynecol Pathol 28:142-7. 2009
    ..In most cases, NE expression is only focally present (< or =10% of the cells). There is no difference in overall survival in patients with or without NE expression...
  37. doi request reprint The interleukin-11 receptor alpha as a candidate ligand-directed target in osteosarcoma: consistent data from cell lines, orthotopic models, and human tumor samples
    Valerae O Lewis
    Section of Orthopedic Oncology, Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer Res 69:1995-9. 2009
    ..These data establish IL-11Ralpha as a candidate target in human osteosarcoma and provide leads for the development of novel imaging and therapeutic agents for the management of this malignant tumor...
  38. doi request reprint Ultrastaging improves detection of metastases in sentinel lymph nodes of uterine cervix squamous cell carcinoma
    Elizabeth D Euscher
    Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Am J Surg Pathol 32:1336-43. 2008
    ..25%. Negative SLN predicts negative non-SLN. For most patients with a positive SLN, the SLN will be the only metastasis detected; a minority of patients with a positive SLN may have a positive non-SLN...
  39. doi request reprint Estrogen receptor immunohistochemistry for confirmation of sentinel lymph node metastasis in cases with equivocal cytokeratin positivity
    Christopher V Nguyen
    Division of Pathology and Laboratory Medicine, The University of Texas, M D Anderson Cancer Center, Houston, TX 77030, USA
    Appl Immunohistochem Mol Morphol 17:139-45. 2009
    ..Although dual ER/CK positivity helps to confirm metastasis, negative ER staining does not exclude metastatic disease...
  40. doi request reprint Diagnostic problems with trophoblastic lesions
    Michael T Deavers
    Department of Pathology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Arch Pathol Lab Med 132:168-74. 2008
    ..The purpose of this review is to address some common problems involving the diagnosis of trophoblastic lesions...
  41. doi request reprint Uterine tumors with neuroectodermal differentiation: a series of 17 cases and review of the literature
    Elizabeth D Euscher
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Am J Surg Pathol 32:219-28. 2008
    ....
  42. pmc Aneurysmal bone cysts recur at juxtaphyseal locations in skeletally immature patients
    Patrick P Lin
    Department of Orthopaedic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230, USA
    Clin Orthop Relat Res 466:722-8. 2008
    ..Meticulous treatment of these cysts is necessary, but we believe an overly aggressive approach that destroys the physis or articular cartilage is not warranted. Preservation of these structures remains a high priority of treatment...
  43. doi request reprint Patterns of low-grade serous carcinoma with emphasis on the nonepithelial-lined spaces pattern of invasion and the disorganized orphan papillae
    Elvio G Silva
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Int J Gynecol Pathol 29:507-12. 2010
    ..In 62% of the cases, in addition to obvious areas of invasion, there were 2 patterns difficult to recognize as invasive, disorganized orphan papillae, and irregular well-developed glands...
  44. doi request reprint Parametrial involvement in radical hysterectomy specimens for women with early-stage cervical cancer
    Michael Frumovitz
    Departments of 1Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Obstet Gynecol 114:93-9. 2009
    ....
  45. ncbi request reprint Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary
    David M Gershenson
    Department of Gynecologic Oncology and Pathology, The University of Texas M D Anderson Cancer Center, Houston, 77230 1439, USA
    Obstet Gynecol 108:361-8. 2006
    ..To analyze the clinical behavior of patients with stage II-IV low-grade serous carcinoma of the ovary seen at our institution who underwent primary surgery followed by platinum-based chemotherapy...
  46. ncbi request reprint Wolffian duct tumors: case reports and review of the literature
    Pedro T Ramirez
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Gynecol Oncol 86:225-30. 2002
    ..Although generally considered a tumor of low malignant potential, these tumors can recur. Two cases are reported here...
  47. doi request reprint Implementation of American Society of Clinical Oncology/College of American Pathologists HER2 Guideline Recommendations in a tertiary care facility increases HER2 immunohistochemistry and fluorescence in situ hybridization concordance and decreases the nu
    Lavinia P Middleton
    Departments of Pathology, The University of Texas M D Anderson Cancer Center, Houston, USA
    Arch Pathol Lab Med 133:775-80. 2009
    ..The American Society of Clinical Oncology/ College of American Pathologists (ASCO/CAP) guideline recommendations from January 2007 identified many sources of immunohistochemistry (IHC) testing variation...
  48. ncbi request reprint Calcifications in ovary and endometrium and their neoplasms
    Elvio G Silva
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Mod Pathol 16:219-22. 2003
    ..This is most probably secondary to metabolic changes, which could be related to hormones and not caused by degenerative changes in epithelial cells...
  49. ncbi request reprint Uterine epithelioid leiomyosarcomas with clear cells: reactivity with HMB-45 and the concept of PEComa
    Elvio G Silva
    Department of Pathology, Box 85, University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Am J Surg Pathol 28:244-9. 2004
    ..In uterine smooth muscle tumors, some epithelioid cells most likely undergo clear cell changes and become positive for HMB-45. It would be advisable to perform this stain in all epithelioid smooth muscle tumors of the uterus...
  50. ncbi request reprint Grading ovarian serous carcinoma using a two-tier system
    Anais Malpica
    Department of Pathology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Am J Surg Pathol 28:496-504. 2004
    ..However, additional studies are required to validate these statements...
  51. ncbi request reprint Overexpression of kallikrein 10 in epithelial ovarian carcinomas
    Hyun S Shvartsman
    Department of Gynecologic Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030 4009, USA
    Gynecol Oncol 90:44-50. 2003
    ..We investigated whether KLK10 and its related protein, hK10, might serve as equally accurate markers for ovarian carcinoma...
  52. ncbi request reprint The activity of taxanes in the treatment of sex cord-stromal ovarian tumors
    Jubilee Brown
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 22:3517-23. 2004
    ..To determine the efficacy and side effects of taxanes, with or without platinum, for the treatment of sex cord-stromal tumors of the ovary...
  53. ncbi request reprint The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas
    Preetha Ramalingam
    Department of Pathology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Am J Surg Pathol 28:1499-505. 2004
    ..CK7 and EMA are essentially negative in YST but are diffusely positive in CCC and EAC, making them useful markers for differentiating YSTs from both CCCs and EACs. Leu-M1 may also be helpful for distinguishing YSTs from CCCs...
  54. ncbi request reprint The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors
    Jubilee Brown
    Department of Gynecologic Oncology, Unit 440, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Gynecol Oncol 97:489-96. 2005
    ..We compared the efficacy and side effects of taxanes, with or without platinum, to bleomycin, etoposide, and cisplatin (BEP) in treating sex cord-stromal ovarian tumors...
  55. ncbi request reprint Undifferentiated carcinoma of the endometrium
    Basel Altrabulsi
    Department of Pathology, Baylor University, 1515 Holcombe Boulevard, Dallas, TX 77030, USA
    Am J Surg Pathol 29:1316-21. 2005
    ..In summary, undifferentiated carcinoma of the endometrium appears to be more aggressive than endometrial endometrioid adenocarcinoma, FIGO grade 3. Its proper recognition is important for prognosis and potentially for therapy...
  56. ncbi request reprint Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma?
    Elvio G Silva
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Int J Gynecol Pathol 25:52-8. 2006
    ..In asynchronous cases, being aware of this association can explain the absence of a second primary...
  57. ncbi request reprint Ovarian involvement by metastatic colorectal adenocarcinoma: still a diagnostic challenge
    Michael R Lewis
    Department of Pathology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Am J Surg Pathol 30:177-84. 2006
    ..Metastatic colorectal adenocarcinoma should be considered in the differential diagnosis of an ovarian mass, even if the mass is large and unilateral or in a young patient, to secure proper treatment of these patients...
  58. ncbi request reprint Treatment and prognosis of chondroblastoma
    Patrick P Lin
    Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX 77230, USA
    Clin Orthop Relat Res 438:103-9. 2005
    ..All three patients died from their disease. Pelvic tumors tend to be biologically more aggressive and more apt to recur locally and metastasize to distant locations...
  59. ncbi request reprint Differential expression of WT-1 in serous carcinomas in the peritoneum with or without associated serous carcinoma in endometrial polyps
    Elizabeth D Euscher
    Department of Pathology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Am J Surg Pathol 29:1074-8. 2005
    ..Additionally, the difference in WT-1 expression between peritoneal serous carcinomas with and without coexistent serous carcinoma in endometrial polyps suggests that peritoneal serous carcinoma may have different pathogenetic pathways...
  60. pmc Microscopic and early-stage ovarian cancers in BRCA1/2 mutation carriers: building a model for early BRCA-associated tumorigenesis
    Melinda S Yates
    Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230, USA
    Cancer Prev Res (Phila) 4:463-70. 2011
    ..We present an updated model for BRCA1/2 mutation-associated ovarian and fallopian tube carcinogenesis, which may aid in identifying improved prevention strategies for high-risk women who delay or decline RRSO...
  61. ncbi request reprint Immunohistochemical analysis of clear cell carcinoma of the gynecologic tract
    R Vang
    Department of Pathology, University of Texas-Houston Medical School, Houston, Texas, USA
    Int J Gynecol Pathol 20:252-9. 2001
    ..Much of its profile is similar to other gynecologic adenocarcinomas, but some of the markers studied may be useful in the differential diagnosis of this tumor...
  62. ncbi request reprint Metastatic melanoma to the vagina: clinicopathologic and immunohistochemical study of three cases and literature review
    Deepali Gupta
    Department of Pathology and Laboratory Medicine, University of Texas Houston Health Science Center, Houston, Texas, USA
    Int J Gynecol Pathol 22:136-40. 2003
    ..One patient underwent wide local excision of tumor followed by chemotherapy, one patient had intracavitary radiotherapy, and one had palliative radiotherapy to the brain only. The patients died after a follow-up of 3, 14, and 48 months...
  63. doi request reprint Thyroid transcription factor-1 expression in ovarian epithelial neoplasms
    Lena A Kubba
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Mod Pathol 21:485-90. 2008
    ..It should also be taken into consideration when evaluating adenocarcinomas involving the lung in patients with a history of a gynecologic malignancy...
  64. doi request reprint Mitosis-specific marker phospho-histone H3 in the assessment of mitotic index in uterine smooth muscle tumors: a pilot study
    Emanuela Veras
    Department of Pathology, The University of Texas Medical School at Houston, Texas 77030, USA
    Int J Gynecol Pathol 28:316-21. 2009
    ....
  65. ncbi request reprint Serous carcinoma of the ovary, fallopian tube, or peritoneum presenting as lymphadenopathy
    Elizabeth D Euscher
    Department of Pathology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Am J Surg Pathol 28:1217-23. 2004
    ..Patients with minimal peritoneal disease and extra-abdominal lymph node metastases survive longer than those with bulky peritoneal disease..
  66. doi request reprint Ovarian intestinal type mucinous borderline tumors: are we ready for a nomenclature change?
    Andres G Chiesa
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Int J Gynecol Pathol 29:108-12. 2010
    ..Caution dictates retaining the current nomenclature to ensure the follow-up of patients affected by this disease until uncertainty regarding the extent of sampling needed to exclude the presence of carcinoma is resolved...
  67. ncbi request reprint Uterine leiomyomas with Eosinophils: a clinicopathologic study of 3 cases
    R Vang
    Department of Pathology, Laboratory of Surgical Pathology, Stanford University Medical Center, Stanford, California, USA
    Int J Gynecol Pathol 20:239-43. 2001
    ..Their presence, however, does not appear to have any clinical significance...
  68. doi request reprint Neovascularization in mucinous ductal carcinoma in situ suggests an alternative pathway for invasion
    S A Gadre
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Histopathology 53:545-53. 2008
    ..The aim was to characterize mucinous DCIS (mDCIS) of the breast and to describe, to our knowledge for the first time, neovascularization in mucin...
  69. ncbi request reprint Vessels within vessels in the myometrium
    S Merchant
    Division of Pathology and Laboratory Medicine, Department of Lymphoma, University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, U S A
    Am J Surg Pathol 26:232-6. 2002
    ..Pathologists should also be able to recognize these spaces as vascular channels in the event that malignant cells are identified within them...
  70. ncbi request reprint Primary adenocarcinoma of the vagina not associated with diethylstilbestrol (DES) exposure
    Steven J Frank
    Division of Radiation Oncology, Unit 97, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Gynecol Oncol 105:470-4. 2007
    ..The purpose of this study was to define the pathologic characteristics of verified NDAV and characterize the outcomes of patients who present with this rare malignancy...
  71. ncbi request reprint Gross deciduosis peritonei obstructing labor: a case report and review of the literature
    Anais Malpica
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Int J Gynecol Pathol 21:273-5. 2002
    ..After a postpartum visit at 5 weeks, the patient was lost to follow-up...
  72. ncbi request reprint Validation of tissue microarray technology in ovarian carcinoma
    Daniel G Rosen
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 4095, USA
    Mod Pathol 17:790-7. 2004
    ....
  73. ncbi request reprint The expression of decorin in human ovarian tumors
    Michael A Nash
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Clin Cancer Res 8:1754-60. 2002
    ..The purpose of this study was to examine ovarian cancer cells for the expression of decorin, a proteoglycan component of the cell matrix that can inhibit cancer cell growth...
  74. ncbi request reprint Metastasis to sigmoid colon mucosa and submucosa from serous borderline ovarian tumor: response to hormone therapy
    E J Lee
    Department of Gynecologic Medical Oncology, The Univerisity of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Int J Gynecol Cancer 16:295-9. 2006
    ....
  75. ncbi request reprint Vaginal melanoma: a clinicopathologic and immunohistochemical study of 26 cases
    Deepali Gupta
    University of Texas Houston Health Science Center, USA
    Am J Surg Pathol 26:1450-7. 2002
    ..S-100 remains the most sensitive marker for these tumors. HMB-45 is negative in 23% cases of vaginal melanoma. Tyrosinase and MART-1 are useful markers when S-100 is negative or only focally positive...
  76. ncbi request reprint Activated SRC protein tyrosine kinase is overexpressed in late-stage human ovarian cancers
    Jon R Wiener
    Department of Molecular Therapeutics, University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Gynecol Oncol 88:73-9. 2003
    ..The objective of this study was to determine if the Src tyrosine kinase is overexpressed and activated in late-stage human ovarian cancers...
  77. ncbi request reprint beta-catenin nuclear localization is associated with grade in ovarian serous carcinoma
    Christine M Lee
    Department of Gynecologic Oncology, University of Texas M D Anderson Cancer Center, TX 77030, Houston, USA
    Gynecol Oncol 88:363-8. 2003
    ..beta-Catenin has been previously associated with oncogenic activity in human cancers. We evaluated whether beta-catenin also plays a role in papillary serous ovarian neoplasms...
  78. ncbi request reprint Immunohistochemical overexpression of p16 and p53 in uterine serous carcinoma and ovarian high-grade serous carcinoma
    Andres G Chiesa-Vottero
    Department of Anatomic Pathology, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Int J Gynecol Pathol 26:328-33. 2007
    ..The overexpression of p16 in USC is unrelated to HPV. Further studies are necessary to determine whether p16 expression is useful in the differential diagnosis of ovarian high-grade serous carcinoma...
  79. ncbi request reprint An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms
    Ciaran J O'Neill
    Department of Pathology, Royal Group of Hospitals Trust, Belfast, Northern Ireland
    Am J Surg Pathol 29:1034-41. 2005
    ..In particular, the differences in p53 immunoreactivity are in keeping with the observation that p53 gene mutation is more common in high-grade than low-grade OSC...
  80. ncbi request reprint Radiation-associated endometrial cancers are prognostically unfavorable tumors: a clinicopathologic comparison with 527 sporadic endometrial cancers
    Bhavana Pothuri
    Department of Obstetrics and Gynecology, Columbia University, New York, NY, USA
    Gynecol Oncol 103:948-51. 2006
    ..Previous reports have suggested that patients who have undergone pelvic radiation for cervical cancer are at risk for developing poorly differentiated endometrial cancers with poor prognoses...
  81. ncbi request reprint Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence
    Akila N Viswanathan
    Department of Radiation Oncology, Brigham and Women s Hospital, Boston, MA, USA
    Gynecol Oncol 93:27-33. 2004
    ..To analyze the sites of relapse and overall survival in women with neuroendocrine marker-positive small cell carcinoma of the cervix...
  82. ncbi request reprint In situ human telomerase reverse transcriptase expression pattern in normal and neoplastic ovarian tissues
    Atac Baykal
    Department of Pathology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Oncol Rep 11:297-302. 2004
    ..We conclude that human telomerase reverse transcriptase mRNA expression does not seem to be a reliable marker for clinical use in differentiating between benign and malignant tumors...
  83. ncbi request reprint Ovarian yolk sac tumor associated with endometrioid carcinoma and mucinous cystadenoma of the ovary
    Jessica M Lopez
    Departamento de Patologia, Hospital de Clinicas Jose de San Martin, Buenos Aires, Argentina
    Ann Diagn Pathol 7:300-5. 2003
    ..After surgery, the patient received three cycles of chemotherapy. However, the disease progressed and the patient died 10 months after the diagnosis of the ovarian tumor...
  84. ncbi request reprint Imatinib mesylate (gleevec)--targeted kinases are expressed in uterine sarcomas
    Jimmy J Caudell
    Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    Appl Immunohistochem Mol Morphol 13:167-70. 2005
    ..These results indicate that many uterine sarcomas express 1 or more of the kinases targeted by imatinib mesylate and that further investigation of imatinib as a therapy for uterine sarcomas is warranted...
  85. ncbi request reprint Development of endometrial cancer after radiation treatment for cervical carcinoma
    Bhavana Pothuri
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Obstet Gynecol 101:941-5. 2003
    ..To detail the Memorial Sloan-Kettering Cancer Center and MD Anderson Cancer Center experience with 23 patients treated with radiation therapy for invasive cervical carcinoma who subsequently developed endometrial carcinoma...
  86. doi request reprint Combined large cell neuroendocrine carcinoma and papillary serous carcinoma of the endometrium with pagetoid spread
    Lorena Posligua
    Departments of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Arch Pathol Lab Med 132:1821-4. 2008
    ..This component was diffusely positive for neuroendocrine markers. Following surgery, the patient was treated with radiation therapy and chemotherapy. She was without evidence of progression at 5 months of follow-up...
  87. ncbi request reprint The association of benign and malignant ovarian adenofibromas with breast cancer and thyroid disorders
    Elvio G Silva
    Department of Pathology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Int J Surg Pathol 10:33-9. 2002
    ..Mutations of PTEN have been found in breast and thyroid cancer. The thyroid and ovaries are controlled by glycoprotein hormones of the pituitary gland, which have common alpha subunits...
  88. ncbi request reprint Metastatic carcinoma of the gallbladder mimicking an advanced cervical carcinoma
    Sergio Martinez-Román
    Institut Clinic de Ginecologia, Obstetricia i Neonatologia, Hospital Clinic, Universitat de Barcelona, Spain
    Gynecol Oncol 97:942-5. 2005
    ..To our knowledge, only three cases of primary carcinoma of the gallbladder with metastasis to the cervix have been previously reported. We report a case of metastatic gallbladder carcinoma mimicking a stage IIIB cervical carcinoma...
  89. ncbi request reprint Metastatic colorectal adenocarcinoma involving the ovary with elevated serum CA125: a potential diagnostic pitfall
    Michael R Lewis
    Department of Pathology, Given Bldg, The University of Vermont College of Medicine, 89 Beaumont Avenue, Burlington, VT 05405, USA
    Gynecol Oncol 105:395-8. 2007
    ....
  90. ncbi request reprint Isolated vulvar Langerhans cell histiocytosis: report of two cases
    Anthony Padula
    Department of Hematopathology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4095, USA
    Int J Gynecol Pathol 23:278-83. 2004
    ..Thus isolated vulvar LCH has the potential for aggressive clinical behavior, either as local recurrence or disseminated disease. New treatment modalities are needed for this disease...